Nordic Nanovector ASA (DE:8NN)
FRANKFURT:8NN
8NN Stock Chart & Stats
€0.30
<€0.01(4.31%)
At close: 4:00 PM EST
€0.30
<€0.01(4.31%)
Day’s Range― - ―
52-Week Range€0.19 - €0.51
Previous CloseN/A
Volume0.00
Average Volume (3M)3.00
Market Cap
€131.87M
Enterprise Value€574.01M
Total Cash (Recent Filing)€123.40M
Total Debt (Recent Filing)€700.00K
Price to Earnings (P/E)―
Beta0.09
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding360,001,830
10 Day Avg. Volume10
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nordic Nanovector ASA News
8NN FAQ
What was Nordic Nanovector ASA’s price range in the past 12 months?
Nordic Nanovector ASA lowest stock price was €0.19 and its highest was €0.51 in the past 12 months.
What is Nordic Nanovector ASA’s market cap?
Nordic Nanovector ASA’s market cap is €131.87M.
When is Nordic Nanovector ASA’s upcoming earnings report date?
Nordic Nanovector ASA’s upcoming earnings report date is Aug 28, 2026 which is in 70 days.
How were Nordic Nanovector ASA’s earnings last quarter?
Nordic Nanovector ASA released its earnings results on Feb 26, 2026. The company reported -€0.007 earnings per share for the quarter, beating the consensus estimate of -€0.009 by €0.002.
Is Nordic Nanovector ASA overvalued?
According to Wall Street analysts Nordic Nanovector ASA’s price is currently Overvalued.
Does Nordic Nanovector ASA pay dividends?
Nordic Nanovector ASA does not currently pay dividends.
What is Nordic Nanovector ASA’s EPS estimate?
Nordic Nanovector ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nordic Nanovector ASA have?
Nordic Nanovector ASA has 360,001,830 shares outstanding.
What happened to Nordic Nanovector ASA’s price movement after its last earnings report?
Nordic Nanovector ASA reported an EPS of -€0.007 in its last earnings report, beating expectations of -€0.009. Following the earnings report the stock price went down -4.557%.
Which hedge fund is a major shareholder of Nordic Nanovector ASA?
Currently, no hedge funds are holding shares in DE:8NN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nordic Nanovector ASA
Established in 2017, Thor Medical ASA, with its headquarters in Oslo, Norway, specializes in the development and provision of alpha-particle emitters for oncology treatments within Norway.
Technical Analysis
Options Prices
Currently, No data available
---